Raptor Pharmaceuticals (RPTP) Crumbles: Stock Falls by 7.2%
Raptor Pharmaceuticals Corp. (RPTP) saw a big move in the last trading session, as the company’s shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend for RPTP, as the stock is now down over 11% since Sep 11.
The biopharmaceutical company has not seen any estimate revision over the past month, and the current year earnings consensus hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, especially on earnings estimates following the recent slump.
RPTP currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Investors interested in the Med–Biomed/Gene industry may consider better-ranked stocks like Cambrex Corporation. (CBM), Gilead Sciences Inc. (GILD) and PDL BioPharma, Inc. (PDLI), each of which holds a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
RAPTOR PHARMACEUTICAL CORP (RPTP): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
PDL BIOPHARMA INC (PDLI): Free Stock Analysis Report
Zacks Investment Research